Fundamental flaws in our current business model must be fixed if our industry is to stay vital and competitive into the next decade.
Getting to an integrated mar-comms model isn't easy. Addressing your agency's lack of digital skills is a good start.
All decisions have an emotional component. Even those, like technology, where we think reason has won the day.
The ad push around "Low T," and ongoing industry criticism, is a reminder to advertise responsibly.
Cultivating relationships digitally is a long-term play. Yet few pharma campaigns are set up for that kind of promotion
Will J&J ever regain its once stellar reputation for ethics and social responsibility?
Remember when it felt good to say you worked in pharma? How to get the people who benefit from our products to recognize and articulate the value they receive
In schizophrenia, non-compliance can be disastrous. Do depot drugs really make a difference for patients?
Why agencies must get out of the strategy business.
The Wizards of White Oak are spending $10 million on DTC ad research. Is this a wise use of sparse agency resources?